Japan’s MHLW Approves Booster Shot for SPIKEVAX®, Moderna’s mRNA COVID-19 Vaccine
The SPIKEVAX® brand name was developed in partnership with Brand Institute, the global leader in pharmaceutical and healthcare-related name development MIAMI, Dec. 20, 2021 /PRNewswire/ -- Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®. The brand name was announced by the...
Novo Nordisk topping the list of Best Places to Work in Bangladesh for 2021
DHAKA, Bangladesh, Dec. 20, 2021 /PRNewswire/ -- Novo Nordisk Bangladesh, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized as the Best Place to Work in Bangladesh for 2021. During the assessment, the company received outstanding scores across several aspects of their workplace such as leadership,...
Novavax and Serum Institute of India Announce World Health Organization Grants Emergency Use Listing for NVX-CoV2373 COVID-19 Vaccine
First EUL granted by WHO for a protein-based COVID-19 vaccine EUL vaccine manufactured and marketed by SII as COVOVAX™ WHO EUL for Nuvaxovid™ currently under assessment; will be completed following European Medicines Agency (EMA) review GAITHERSBURG, Md. and PUNE, India, Dec. 20, 2021 /PRNewswire/ -- Novavax, Inc....
Novo Nordisk among the top 3 Best Places to Work in Singapore for 2021
Singapore, Dec. 20, 2021 Novo Nordisk Singapore, an affiliate of the global healthcare company with more than 95 years of innovation and leadership in diabetes care, has recently been recognized among the top 3 Best Places to Work for 2021. During the assessment, the company received outstanding scores across several aspects of their workplace such as leadership, teamwork and relationships,...
ZEPP HEALTH REPORTS SURGE IN GLOBAL SHIPMENTS IN Q3 2021
CUPERTINO, Calif., Dec. 17, 2021 /PRNewswire/ -- Zepp Health (NYSE: ZEPP) continued its robust growth in global adult watch shipments in the third quarter of 2021, according to the Q3 2021 Quarterly Wearable Device Tracker by the International Data Corporation (IDC) - a leading market intelligence firm specialized in information technology. The global shipments of Zepp Health's two independent brands,...
Antengene Announces NDA Approval by NMPA for XPOVIO®, China’s First XPO1 inhibitor, for the Treatment of Adults with Relapsed or Refractory Multiple Myeloma
SHANGHAI and HONG KONG, Dec. 17, 2021 /PRNewswire/ -- Antengene Corporation Limited (the "Company" or "Antengene") is pleased to announce that ATG-010 (selinexor, brand name: XPOVIO®), a first-in-class, oral Selective Inhibitor of Nuclear Export (SINE) compound has received conditional approval for marketing by the National Medical Products Administration (the "NMPA"), applicable in combination...
Thailand Launches ASEAN’s First 5G Smart Hospital
BANGKOK, Dec. 17, 2021 /PRNewswire/ -- Yesterday, Office of The National Broadcasting and Telecommunications Commission (NBTC), Siriraj Hospital, and Huawei Technologies (Thailand) Co., Ltd. jointly launched the "Siriraj World Class 5G Smart Hospital". This is the first and largest 5G smart hospital project in the ASEAN region. It will deliver a more efficient and convenient experience to patients by...
Senhwa’s Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Medulloblastoma
TAIPEI and SAN DIEGO, Dec. 17, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for Silmitasertib, a highly selective inhibitor of...
Westlake Omics Authorized as the Exclusive Distributor and Service Provider of Pressure BioSciences, Inc. in China
HANGZHOU, China, Dec. 17, 2021 /PRNewswire/ -- The Agreement signed by Westlake Omics (Hangzhou) Biotechnology Co., Ltd (hereinafter referred to as Westlake Omics) and Pressure BioSciences, Inc. (hereinafter referred to as PBI) on December 3, 2021 authorized Westlake Omics as the exclusive distributor and service provider for PBI's PCT Sample Preparation System Platform and related products in China, a...
Study on Anti-aging with TCM Strides Forward
SHIJIAZHUANG, China, Dec. 17, 2021 /PRNewswire/ -- The opinions of experts on "Study on Anti-aging with Bazi Bushen Capsules Guided by Qi Collateral Theory" were released in Shijiazhuang, Hebei on December 15. According to the opinions, the preliminary research of the project has created the theory of essence, qi and spirit based on the qi collateral theory for the...
